Skip to main content
. Author manuscript; available in PMC: 2011 Nov 4.
Published in final edited form as: Breast Cancer Res Treat. 2010 Feb 7;123(2):525–530. doi: 10.1007/s10549-010-0775-5

Table 2. Odds ratios (ORs)a and 95% confidence intervals (CIs) for the previously reported rs4415084 and rs10941679 SNPs.

SNP High-risk allele frequency (%) Heterozygous
OR (95% CI)
Homozygous
OR (95% CI)
Per-allele
OR (95% CI)
P for trend

Cases (N) Controls (N)
rs4415084_T
 All cases 63.4 (868) 60.5 (1,075) 1.10 (0.84, 1.44) 1.26 (0.96, 1.65) 1.13 (0.99, 1.28) 0.06
 ER + cases 65.7 (262) 1.16 (0.76, 1.77) 1.51 (0.99, 2.31) 1.25 (1.02, 1.52) 0.03
 ER− cases 60.3 (172) 0.81 (0.51, 1.29) 0.87 (0.55, 1.40) 0.96 (0.76, 1.21) 0.96
rs10941679_G
 All cases 18.7 (846) 16.7 (1,056) 1.27 (1.04, 1.56) 0.98 (0.61, 1.58) 1.14 (0.97, 1.35) 0.11
 ER + cases 20.0 (258) 1.35 (1.00, 1.83) 1.12 (0.56, 2.22) 1.21 (0.95, 1.53) 0.10
 ER− cases 17.2 (170) 1.17 (0.81, 1.69) 1.04 (0.45, 2.40) 1.10 (0.82, 1.47) 0.84
a

Adjusted for age, geographical region of residence, place of birth, and percent European admixture